SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-038634
Filing Date
2020-08-10
Accepted
2020-08-10 08:06:07
Documents
3
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ovid-8k_20200810.htm 8-K 28957
2 EX-99.1 ovid-ex991_6.htm EX-99.1 146771
3 GRAPHIC g3duxdtdm2sd000001.jpg GRAPHIC 4722
  Complete submission text file 0001564590-20-038634.txt   183514
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 201087188
SIC: 2834 Pharmaceutical Preparations